Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Aktionärsstruktur

Inhaber in %
Freefloat 99.82
The Vanguard Group, Inc. 9.53
Vanguard Group, Inc. (Subfiler) 9.11
SSgA Funds Management, Inc. 5.52
State Street Corp. 5.52
Vanguard Total Stock Market ETF 3.14
BlackRock Fund Advisors 2.89
Vanguard 500 Index Fund 2.47
BlackRock Institutional Trust Co. NA 2.21
Geode Capital Management LLC 2.13
State Farm Investment Management Corp. 1.32
Capital Research & Management Co. (International Investors) 1.20
SPDR S&P 500 ETF Trust 1.19
Fidelity 500 Index Fund 1.18
Norges Bank (13F) 1.08

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2019 2020 2021 2023
Personal am Ende des Jahres 132'200 134'500 141'700 131'900
Umsatz pro Mitarbeiter in Mio. EUR 0.62 0.61 0.66 0.65

Bilanz (in Mio. EUR) - Aktiva

2019 2020 2021 2023
Summe Umlaufvermögen 45'274 51'237 60'979 53'495
Summe Anlagevermögen 88'152 99'644 108'774 99'206
Summe Aktiva 157'728 174'894 182'018 167'558

Bilanz (in Mio. EUR) - Passiva

2019 2020 2021 2023
Gesamtverschuldung/ -verbindlichkeiten 28'681 36'366 34'751 30'432
Summe Fremdkapital 98'257 111'616 107'995 98'784
Summe Eigenkapital 59'471 63'278 74'023 68'774
Summe Passiva 157'728 174'894 182'018 167'558

Adresse

One Johnson & Johnson Plaza, 08933 New Brunswick
Telefon +1 (732) 524-0400
URL http://www.jnj.com

Management

A. Eugene Washington
Independent Director
Ahmet Tezel
Global Head-Research & Development
Anne M. Mulcahy
Lead Independent Director
Bernardo Tavares
Chief Information Officer
Caroline Tillett
Global Head-Consumer Health
D. Scott Davis
Independent Director
Darius Adamczyk
Independent Director
Elizabeth Forminard
Executive Vice President & General Counsel
Eugene A. Woods
Director
Frederic H. Moll
Chief Development Officer
George Davy
Global HR Director
Hubert Joly
Independent Director
James D. Swanson
Global Chief Information Officer & Executive VP
Jennifer A. Doudna
Independent Director
Jennifer L. Taubert
EVP & Worldwide Chairman-Pharmaceuticals
Jessica Moore
Vice President-Investor Relations
Joaquin Duato
Chairman & Chief Executive Officer
Jonathan Sheh
Director-Workplace Experience
Joseph J. Wolk
Chief Financial Officer & Executive Vice President
Kathleen M. Widmer
Group Chairman-Consumer North America
Kathryn E. Wengel
Chief Technical Operations & Risk Officer
Lisa Paley
Vice President-US Sales
Lisa Romanko
Senior Director-Investor Relations
Marc Larkins
Secretary
Marillyn A. Hewson
Independent Director
Mark Alan Weinberger
Independent Director
Mark B. McClellan
Independent Director
Mary C. Beckerle
Independent Director
Matthew Stuckley
Senior Finance Director
Meredith Stevens
Vice President
Michael Bzdak
Global Dir-Employee Engagement-Global Cmnty Impact
Nadja Y. West
Independent Director
Neil Ackerman
Head-Innovation, Global Supply & Transformation
Paul Ruh
Chief Financial Officer-Consumer Health
Paula A. Johnson
Independent Director
Peter M. Fasolo
Chief Human Resources Officer & Executive VP
Robert J. Decker
Chief Accounting Officer & Controller
Ronald A. Kapusta
Chief Accounting Officer & Controller
Scott White
Company Group Chairman
Thomas J. Spellman
Secretary
Warren Foust
President-Surgical Vision
William E. Cohn
Vice President-Medical Devices

Eintrag hinzufügen

Erfolgreich hinzugefügt!. Zu Portfolio/Watchlist wechseln.

Es ist ein Fehler aufgetreten!

Kein Portfolio vorhanden. Bitte zusätzlich den Namen des neuen Portfolios angeben. Keine Watchlisten vorhanden. Bitte zusätzlich den Namen der neuen Watchlist angeben.

CHF
Hinzufügen